The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls

被引:18
|
作者
Bettencourt, Conceicao [1 ,2 ,3 ]
Santos, Cristina [1 ,2 ,4 ]
Montiel, Rafael [5 ]
Kay, Teresa [6 ]
Vasconcelos, Joao [7 ]
Maciel, Patricia [8 ]
Lima, Manuela [1 ,2 ,3 ]
机构
[1] Univ Azores, Ctr Res Nat Resources CIRN, P-9501801 Ponta Delgada, Azores, Portugal
[2] Univ Azores, Dept Biol, P-9501801 Ponta Delgada, Azores, Portugal
[3] Univ Porto, IBMC, P-4100 Oporto, Portugal
[4] Univ Autonoma Barcelona, Unitat Antropol Biol, Dep Biol Anim Biol Vegetal & Ecol, E-08193 Barcelona, Spain
[5] CINVESTAV IPN, Lab Nacl Genom Biodiversidad, Irapuato, Mexico
[6] Hosp D Estefania, Dept Clin Genet, Lisbon, Portugal
[7] Hosp Divino Espirito Santo, Dept Neurol, Ponta Delgada, Portugal
[8] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
关键词
MJD; SCA3; CAG repeats; transcript variation; polyglutamine disorders; CLINICAL-FEATURES; SOMATIC MOSAICISM; AZORES ISLANDS; REPEAT; CEREBELLAR; FAMILIES; SYSTEM; MJD;
D O I
10.1038/ejhg.2009.215
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder of late onset (occurring at a mean age of 40.2 years). The clinical manifestation of MJD is dependent on the presence of an expansion of the (CAG)(n) motif within exon 10 of the ATXN3 gene, located at 14q32.1. The variance in onset of MJD is only partially correlated (similar to 50-80%) with the extension of the CAG tract in genomic DNA (gDNA). The main aim of this work was to determine whether there are discrepancies in the size of the (CAG)(n) tract between gDNA and mRNA, and to establish whether there is a better association between age at onset and repeat size at the mRNA level. We typed gDNA and cDNA samples for the (CAG)(n) tract totalizing 108 wild-type and 52 expanded ATXN3 alleles. In wild-type alleles no differences were found between gDNA and cDNA. In expanded alleles, the CAG repeat size in gDNA was not always directly transcribed into the mRNA; on average there were differences of +1 repeat at the cDNA level. The slight discrepancies obtained were insufficient to cause significant differences in the distribution of the expanded alleles, and therefore no improvement in onset variance explanation was obtained with mRNA. European Journal of Human Genetics (2010) 18, 621-623; doi:10.1038/ejhg.2009.215; published online 25 November 2009
引用
收藏
页码:621 / 623
页数:3
相关论文
共 50 条
  • [31] CORRELATION BETWEEN CAG REPEAT LENGTH AND CLINICAL-FEATURES IN MACHADO-JOSEPH DISEASE
    MACIEL, P
    GASPAR, C
    DESTEFANO, AL
    SILVEIRA, I
    COUTINHO, P
    RADVANY, J
    DAWSON, DM
    SUDARSKY, L
    GUIMARAES, J
    LOUREIRO, JEL
    NEZARATI, MM
    CORWIN, LI
    LOPESCENDES, I
    ROOKE, K
    ROSENBERG, R
    MACLEOD, P
    FARRER, LA
    SEQUEIROS, J
    ROULEAU, GA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (01) : 54 - 61
  • [32] Modelling Machado-Joseph Disease in patientderived isogenic lines by CRISPR/Cas9-mediated correction of ATXN3-CAG expansion
    Perdigao, P.
    Matos, C.
    Lopes, S.
    Fernandes, R.
    Lopes, M.
    Conceicao, A.
    Faro, R.
    Santana, M.
    Adao, D.
    Rufino-Ramos, D.
    Leandro, K.
    Nobre, R.
    de Almeida, L. Pereira
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A119 - A119
  • [33] Intranuclear inclusions, neuronal loss and CAG mosaicism in two patients with Machado-Joseph disease
    Muñoz, E
    Rey, MJ
    Milà, M
    Cardozo, A
    Ribalta, T
    Tolosa, E
    Ferrer, I
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 200 (1-2) : 19 - 25
  • [34] CAG EXPANSIONS IN A NOVEL GENE FOR MACHADO-JOSEPH DISEASE AT CHROMOSOME 14Q32.1
    KAWAGUCHI, Y
    OKAMOTO, T
    TANIWAKI, M
    AIZAWA, M
    INOUE, M
    KATAYAMA, S
    KAWAKAMI, H
    NAKAMURA, S
    NISHIMURA, M
    AKIGUCHI, I
    KIMURA, J
    NARUMIYA, S
    KAKIZUKA, A
    NATURE GENETICS, 1994, 8 (03) : 221 - 228
  • [35] CAG EXPANSIONS IN A NOVEL GENE FOR MACHADO-JOSEPH DISEASE AT CHROMOSOME-14Q32.1
    KAKIZUKA, A
    KAWAGUCHI, Y
    OKAMOTO, T
    NARUMIYA, S
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S216 - S216
  • [36] Population genetics of wild-type CAG repeats in the Machado-Joseph disease gene in Portugal
    Lima, M
    Costa, MC
    Montiel, R
    Ferro, A
    Santos, C
    Silva, C
    Bettencourt, C
    Sousa, A
    Sequeiros, J
    Coutinho, P
    Maciel, P
    HUMAN HEREDITY, 2005, 60 (03) : 156 - 163
  • [37] Machado-Joseph disease: Correlation between the clinical features, the CAG repeat length and homozygosity for the mutation
    Lerer, I
    Merims, D
    Abeliovich, D
    Zlotogora, J
    Gadoth, N
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1996, 4 (01) : 3 - 7
  • [38] Retinopathy associated with Machado-Joseph disease (spinocerebellar ataxia 3) with CAG trinucleotide repeat expansion
    Isashiki, Y
    Kii, Y
    Ohba, N
    Nakagawa, M
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (06) : 808 - 810
  • [39] (CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China
    Chen, Zhao
    Zheng, Caifa
    Long, Zhe
    Cao, Li
    Li, Xunhua
    Shang, Huifang
    Yin, Xinzhen
    Zhang, Baorong
    Liu, Jingyu
    Ding, Dongxue
    Peng, Yun
    Wang, Chunrong
    Peng, Huirong
    Ye, Wei
    Qiu, Rong
    Pan, Qian
    Xia, Kun
    Chen, Shengdi
    Sequeiros, Jorge
    Ashizawa, Tetsuo
    Klockgether, Thomas
    Tang, Beisha
    Jiang, Hong
    BRAIN, 2016, 139
  • [40] CRISPR-Cas9-Mediated Pre-Transcriptional Silencing of Mutant ATXN3 Decreases Motor Impairments of an In Vivo Machado-Joseph Disease Model
    Matos, Carlos
    Pena, Frederico
    Conceicao, Andre
    Lopes, Sara
    Duarte, Sonia
    Miranda, Catarina
    de Almeida, Luis Pereira
    MOLECULAR THERAPY, 2019, 27 (04) : 120 - 121